MEF2C and adenoma: Then, we validated the findings in our CRCs, and further among our additional non-advanced adenomas (NAAs), advanced adenomas (AAs), and CRCs to assess the MEF2C-AS1 methylation status and expression changes at all stages of colorectal carcinogenesis.